Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01217723
What this trial is testing

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Who this might be right for
Hematologic Malignancies
McMaster University 198
Testing effectiveness (Phase 2)Study completedNCT04112810
What this trial is testing

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Hematologic Malignancies
Medical College of Wisconsin 51
Not applicableStudy completedNCT02188290
What this trial is testing

Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 178
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Not applicableAvailableNCT04745637
What this trial is testing

Managed Access Programs for INC424, Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)WithdrawnNCT00640497
What this trial is testing

Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Henogen 12
Early research (Phase 1)Study completedNCT00967096
What this trial is testing

Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)

Who this might be right for
MalignancyBone Marrow Transplantation
Emory University 20
Large-scale testing (Phase 3)Study completedNCT01002742
What this trial is testing

Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

Who this might be right for
Graft-versus-Host DiseaseImmune System Disorders
Medical College of Wisconsin 236
Not applicableWithdrawnNCT01569373
What this trial is testing

Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Who this might be right for
Blood Stem Cell Transplant Failure
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT04910152
What this trial is testing

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Who this might be right for
Acute Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
Hannah Choe, MD 2
Large-scale testing (Phase 3)Study completedNCT02913261
What this trial is testing

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Corticosteroid Refractory Acute Graft vs Host Disease
Novartis Pharmaceuticals 310
Testing effectiveness (Phase 2)WithdrawnNCT04059757
What this trial is testing

Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD

Who this might be right for
Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)
Leland Metheny
Not applicableWithdrawnNCT06200441
What this trial is testing

Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease

Who this might be right for
Acute Myeloid Leukemia, AdultGraft Versus Host DiseaseEndothelial Dysfunction
Ugur Arzu Kulu
Testing effectiveness (Phase 2)Ended earlyNCT03721965
What this trial is testing

Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects

Who this might be right for
Acute Graft-versus-host Disease
Incyte Corporation 2
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Very early researchUnknownNCT05094765
What this trial is testing

Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD

Who this might be right for
GVHD
Shenzhen Xbiome Biotech Co., Ltd. 15
Early research (Phase 1)WithdrawnNCT06444022
What this trial is testing

HAESCs Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Graft Versus Host Disease
Nanfang Hospital, Southern Medical University
Not applicableUnknownNCT01227122
What this trial is testing

NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure

Who this might be right for
Preoperative KIDNEY FAILURE, CHRONICPostoperative KIDNEY FAILURE, ACUTECardiac Surgical Procedures
Hopital Jean Minjoz 100
Next Page